About 4 000 reports

Latvia Pharmaceuticals and Healthcare Report Q2 2015

103 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Market growth forecasts are strong although the country will continue to present a modest opportunity to larger multinational companies on account of its relatively small market size. Meanwhile, tensions between Ukraine and Russia may provide challenges for local manufacturers...

915 1 208 759
Apr 2015

China Pharmaceuticals and Healthcare Report Q2 2015

198 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Pharmaceutical sales in China will continue to grow robustly - boosted by the improvement in healthcare access, liberalisation of the industry as well as an epidemiological transition towards chronic diseases. This will present strong revenue earning opportunities for...

915 1 208 759
Apr 2015

Botswana Pharmaceuticals and Healthcare Report Q2 2015

66 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: With Botswana's plans to manufacture drugs locally stalling, the country will remain reliant on importing its pharmaceutical needs for the foreseeable future. The government's commitment to healthcare sector development will continue driving import growth to outperform...

915 1 208 759
Apr 2015

Brazil Pharmaceuticals and Healthcare Report Q2 2015

144 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Continued regulatory improvements, growing pharmaceutical and healthcare markets, and increased favour for foreign investment will allow Brazil to maintain its position as the regional outperformer in Latin America. However, low affordability and increasing generic drug...

915 1 208 759
Apr 2015

Austria Pharmaceuticals and Healthcare Report Q2 2015

71 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Austrian pharmaceutical and healthcare sectors are well developed and stable, offeringsome of the most attractive opportunities in the region. Our updated forecasts indicate a continuing moderate rebound in both pharmaceutical and healthcare expenditure in 2015...

915 1 208 759
Apr 2015

Research and Investment Forecast Evaluation of China’s Enteral Nutrition Preparation Market from 2015 to 2020

59 pages • By Huidian Research

5. Development of Enteral Nutrition Preparation in China5.1 Market Status Quo and ForecastEnteral nutrition preparations are the main varieties in enteral nutrition support treatment. The oral enteral nutrition emulsion and suspension include TPF?TP?TPF-T and TP-HE etc different formulas. The main manufacturers are Sino-Swed Pharmaceutical...

1 600 2 000 1 280
Mar 2015

Philippines Pharmaceuticals and Healthcare Report Q2 2015

129 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Philippine government will face growing headwinds in attracting innovative drugmakers to expand their operations in the country due to the rising domestic use of generic drugs and the logistical risks preventing companies from using it as a regional distribution hub....

985 1 300 818
Mar 2015

Estonia Pharmaceuticals and Healthcare Report Q2 2015

100 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Positive consumer dynamics will drive growth in pharmaceutical sales in Estonia. We see anopportunity emerging as the Baltic countries of Lithuania, Latvia and Estonia jointly procure pharmaceuticals for their collective needs. Despite the small size of Estonia's...

985 1 300 818
Mar 2015

Qatar Pharmaceuticals and Healthcare Report Q2 2015

104 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: With Qatar being the least exposed of the Gulf Cooperation Council (GCC) countries to lower oil prices, government spending on healthcare will remain elevated. Access to medicines will be improved following the implementation of the second phase of the GCC drug price...

985 1 300 818
Mar 2015

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015

84 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, causing the country's healthcare system to continue to rely on funding from donor partners and developmental agencies. Political and economic uncertainty will continue...

985 1 300 818
Mar 2015

Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015

82 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved healthcare access. While many opportunities may arise for market players, Sri Lanka is burdened by a prevalence of corruption and price controls, while also being...

985 1 300 818
Mar 2015

United States Pharmaceuticals and Healthcare Report Q2 2015

124 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The US pharmaceutical market's status as the most lucrative globally is unassailable. This is due to unparalleled healthcare access, considerable spending power, a high burden of disease, minimal market access barriers and intense company activity. The key risks to this...

985 1 300 818
Mar 2015

Saudi Arabia Pharmaceuticals and Healthcare Report Q2 2015

128 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Saudi Arabia will deliver on its intentions to increase spending for the healthcare sector in 2015, despite lower oil prices. The government regards the sector as pivotal to political stability and we believe that actual spending will yet again exceed the amount budgeted...

985 1 300 818
Mar 2015

United Kingdom Pharmaceuticals and Healthcare Report Q2 2015

112 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in the UK. On the pharmaceutical front, the UK is a key international player, and will continue to be for the foreseeable future. However, the climate of cost containment,...

985 1 300 818
Mar 2015

Bahrain Pharmaceuticals and Healthcare Report Q2 2015

100 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: We uphold our view that Bahrain's pharmaceutical and healthcare sector will maintain strong and consistent growth over our forecast period. We believe that the country's ageing population will help drive medicine demand along with an increasing chronic disease burden...

985 1 300 818
Mar 2015

Finland Pharmaceuticals and Healthcare Report Q2 2015

75 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Finland's pharmaceutical sector's growth is slowing, as is the case with many other mature western countries. The government is continually looking to new reforms and price control policies as it attempts to reduce spiralling healthcare costs associated with the country's...

985 1 300 818
Mar 2015

Belarus Pharmaceuticals and Healthcare Report Q2 2015

88 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The volatility of the Belarusian rouble and high inflation will hurt consumer incomes and therefore the growth outlook of the pharmaceutical market over the next two years. Furthermore, increased scrutiny by President Lukashenko over pharmaceutical imports indicates that...

985 1 300 818
Mar 2015

Cuba Pharmaceuticals and Healthcare Report Q2 2015

76 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Cuban government's strong commitment to its pharmaceutical and healthcare sector, as shown through growing investment, will ensure the continued development of Cuba's healthcare market. Recent talks between Cuba and the US, increases to trade relations which boost...

985 1 300 818
Mar 2015

Global Osteoarthritis Market 2015-2019

93 pages • By Infiniti Research Limited

About OAOA is a condition in which the cartilage, a material that cushions the joints, breaks down. This leads to stiffness, inflammation, pain, and loss of joint movement. The exact etiology of OA is not fully understood. Obesity, overuse of the joint, weak thigh muscles, aging, and genetics are some of the common risk factors of OA;...

2 000 2 500 1 600
Mar 2015

Global Gaucher Disease Market 2015-2019

88 pages • By Infiniti Research Limited

About Gaucher DiseaseGaucher disease is a rare, inherited metabolic disorder caused by the deficiency of the enzyme glucocerebrosidase. This in turn causes the accumulation of certain detrimental lipids in the body, especially the glycolipid glucocerebroside. The lipids are accumulated mainly within the macrophages, blood cells, spleen,...

2 400 3 000 1 920
Mar 2015

Cancer Drug News 16 MARCH 2015

16 pages • By Espicom Business Intelligence

Industry Trend Analysis - Targeted Oncology Medicine Continues To Drive SpendingIndustry Brief - Eisai's Halaven To Remain On NCDF Pending ReconsiderationIndustry Brief - Puma Initiates PB272 Phase II Trial In Early-Stage HER2-Positive BCIndustry Brief - AB Science Plans Next Step With Masitinib Following Positive PII Data In TNBCIndustry...

825 1 114 685
Mar 2015

HER-2 Positive Breast Cancer Market in the US 2015-2019

108 pages • By Infiniti Research Limited

About HER-2 Positive Breast Cancer Breast cancer is characterized by uncontrolled growth of cancerous cells in the breast. It occurs in both males and females, however, the incidence of breast cancer in males is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer, and other undifferentiated...

2 400 3 000 1 920
Mar 2015

Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015

63 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are commonplace. The state is also heavily reliant on importing its medicines, though over the long-term we believe this reliance will decrease as the government is committed to developing domestic...

985 1 300 818
Mar 2015

Kazakhstan Pharmaceuticals and Healthcare Report Q2 2015

93 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Within the pharmaceutical sector, the Kazakh government is looking to reduce its import reliance and also to serve its growing healthcare needs. In light of the Kazakh government's commitment to ramping up healthcare expenditure and incentivising foreign investment, we...

985 1 300 818
Mar 2015

Belgium Pharmaceuticals and Healthcare Report Q2 2015

104 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Despite a renewed focus on cost-containment, multinational drugmakers will continue to see a high level of potential reward from operations in Belgium. Initiatives intended to reduce public-sector pharmaceutical reimbursement spending will be greatly frustrated by both...

985 1 300 818
Mar 2015

Ukraine Pharmaceuticals and Healthcare Report Q2 2015

107 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: In the short-term, Ukraine's pharmaceutical market will continue to suffer from the impact of its tenuous economic position, the civil unrest in the economic heartlands of Eastern Ukraine and the severe erosion of consumer purchasing power resulting from a significant...

985 1 300 818
Mar 2015

Sweden Pharmaceuticals and Healthcare Report Q2 2015

115 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Sweden's epidemiological profile will continue to be attractive to manufacturers of medicines for non-communicable diseases. Despite the relative rapid uptake of innovative pharmaceuticals, the burden of chronic conditions will increase over the next 15 years. Presenting...

985 1 300 818
Mar 2015

Chile Pharmaceuticals and Healthcare Report Q2 2015

106 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Chile will become an increasingly attractive location for investment by multinational drugmakers as the centre-left government continues to expand public access to and spending on health services and rising incidence of chronic, non-communicable disease support greater...

985 1 300 818
Mar 2015

Herbal/Traditional Products in Egypt

23 pages • By Euromonitor International

There is a general preference for packaged herbal/traditional products over unpackaged alternatives, due to Egyptian consumers’ increasing focus on hygiene, the products’ wide availability and reasonable prices. However, ongoing and intensifying financial pressures at the end of the review period resulted in many consumers switching from packaged...

540 718 481
Mar 2015

Adult Mouth Care in Egypt

21 pages • By Euromonitor International

The adult mouth care category is still considered to be in its nascent stage of development. Although there is a large number of brands present, ranging from expensive to relatively low cost, there is poor distribution and low consumer awareness of the products in this category and how they might offer a different level of care to toothpaste,...

540 718 481
Mar 2015